Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
9.29E-11
|
-2.48E-01
|
-1.19E+00 |
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
1.97E-05
|
-2.24E-01
|
-1.05E+00 |
Asthma
|
CA23 |
Nasal and bronchial airway |
9.09E-03
|
1.48E-01
|
1.19E-01 |
Behcet's disease
|
4A62 |
Peripheral blood |
9.47E-01
|
8.89E-02
|
3.67E-01 |
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
3.17E-01
|
6.58E-02
|
3.75E-01 |
Bladder cancer
|
2C94 |
Bladder tissue |
1.51E-16
|
-1.34E+00
|
-1.00E+01 |
Breast cancer
|
2C60-2C6Z |
Breast tissue |
2.18E-01
|
-5.02E-02
|
-9.77E-02 |
Colon cancer
|
2B90 |
Colon tissue |
1.47E-01
|
1.56E-02
|
4.20E-02 |
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
8.43E-01
|
-2.11E-01
|
-2.22E-01 |
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
4.95E-02
|
-1.85E-01
|
-1.22E+00 |
Gastric cancer
|
2B72 |
Gastric tissue |
3.28E-02
|
-1.17E+00
|
-2.73E+00 |
Glioblastopma
|
2A00.00 |
Nervous tissue |
9.73E-02
|
-3.58E-03
|
-7.50E-03 |
Head and neck cancer
|
2D42 |
Head and neck tissue |
1.80E-17
|
-7.81E-01
|
-1.59E+00 |
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
4.62E-01
|
1.31E-01
|
2.45E-01 |
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
7.93E-01
|
-5.69E-02
|
-1.10E-01 |
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
9.24E-02
|
-6.32E-02
|
-4.10E-01 |
Ischemic stroke
|
8B11 |
Peripheral blood |
7.99E-01
|
-6.21E-02
|
-2.43E-01 |
Liver cancer
|
2C12.0 |
Liver tissue |
3.30E-17
|
9.19E-01
|
1.89E+00 |
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
2.62E-01
|
1.66E-01
|
2.89E-01 |
Lung cancer
|
2C25 |
Lung tissue |
1.11E-01
|
-4.15E-02
|
-7.47E-02 |
Lupus erythematosus
|
4A40 |
Whole blood |
2.64E-02
|
-1.01E-01
|
-2.27E-01 |
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
2.32E-01
|
-1.10E-02
|
-6.65E-02 |
Multiple myeloma
|
2A83.1 |
Bone marrow |
2.40E-03
|
1.08E-01
|
7.89E-01 |
Multiple myeloma
|
2A83.1 |
Peripheral blood |
6.78E-01
|
8.78E-02
|
4.45E-01 |
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
4.09E-01
|
-2.21E-01
|
-4.19E-01 |
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
1.41E-01
|
-1.76E-01
|
-3.82E-01 |
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
5.45E-02
|
-2.57E-01
|
-4.43E-01 |
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
6.06E-08
|
1.26E+00
|
4.00E+00 |
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
1.11E-01
|
-7.85E-02
|
-4.13E-01 |
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
8.90E-01
|
2.00E-01
|
3.31E-01 |
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
1.56E-02
|
2.03E-01
|
1.47E+00 |
Oral cancer
|
2B6E |
Oral tissue |
7.54E-03
|
-4.03E-01
|
-5.47E-01 |
Ovarian cancer
|
2C73 |
Ovarian tissue |
3.18E-03
|
-1.61E+00
|
-1.80E+00 |
Pancreatic cancer
|
2C10 |
Pancreas |
4.53E-01
|
-1.09E-01
|
-1.94E-01 |
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
2.00E-01
|
-2.22E-01
|
-9.50E-01 |
Pituitary cancer
|
2D12 |
Pituitary tissue |
1.07E-02
|
-6.35E-01
|
-1.37E+00 |
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
5.30E-02
|
1.08E-01
|
9.22E-01 |
Pompe disease
|
5C51.3 |
Biceps muscle |
9.70E-02
|
1.25E-01
|
3.16E-01 |
Prostate cancer
|
2C82 |
Prostate |
4.58E-02
|
-4.91E-01
|
-8.60E-01 |
Psoriasis
|
EA90 |
Skin |
2.06E-20
|
6.66E-01
|
1.72E+00 |
Rectal cancer
|
2B92 |
Rectal colon tissue |
4.78E-01
|
-8.78E-02
|
-2.83E-01 |
Renal cancer
|
2C90-2C91 |
Kidney |
3.53E-01
|
-1.08E-01
|
-1.62E-01 |
Retinoblastoma
|
2D02.2 |
Uvea |
3.48E-09
|
1.84E+00
|
4.21E+00 |
Schizophrenia
|
6A20 |
Prefrontal cortex |
4.70E-02
|
-2.04E-01
|
-1.36E-01 |
Schizophrenia
|
6A20 |
Superior temporal cortex |
9.89E-01
|
-7.51E-02
|
-3.62E-01 |
Scleroderma
|
4A42.Z |
Whole blood |
6.39E-01
|
-1.86E-01
|
-9.23E-01 |
Seizure
|
8A60-8A6Z |
Whole blood |
3.70E-01
|
-3.42E-02
|
-1.62E-01 |
Sepsis with septic shock
|
1G41 |
Whole blood |
2.51E-21
|
-2.46E-01
|
-9.03E-01 |
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
6.76E-02
|
-9.03E-02
|
-2.87E-01 |
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
7.23E-01
|
-6.45E-02
|
-2.38E-01 |
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
8.24E-01
|
2.22E-01
|
6.66E-01 |
Skin cancer
|
2C30-2C3Z |
Skin |
3.98E-38
|
-6.21E-01
|
-1.21E+00 |
Thrombocythemia
|
3B63 |
Whole blood |
6.82E-01
|
-5.03E-02
|
-5.06E-01 |
Thrombocytopenia
|
3B64 |
Whole blood |
6.06E-01
|
3.23E-01
|
5.77E-01 |
Thyroid cancer
|
2D10 |
Thyroid |
2.98E-03
|
-1.13E-01
|
-2.53E-01 |
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
3.37E-01
|
1.30E-01
|
3.52E-01 |
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
1.01E-01
|
-2.85E-01
|
-1.85E+00 |
Type 2 diabetes
|
5A11 |
Liver tissue |
5.59E-01
|
2.00E-01
|
4.03E-01 |
Ureter cancer
|
2C92 |
Urothelium |
5.23E-01
|
5.10E-02
|
2.29E-01 |
Uterine cancer
|
2C78 |
Endometrium tissue |
2.95E-12
|
-5.03E-01
|
-7.46E-01 |
Vitiligo
|
ED63.0 |
Skin |
3.39E-01
|
1.17E-01
|
3.27E-01 |
------------------------------------------------------------------------------------ |
|
|
|
|
|